During the five years before people show the first clinical signs of multiple sclerosis (MS), they are...
Our news web pages include ground-breaking multiple sclerosis news and research from around the world.
These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.
Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.
We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years.
During the five years before people show the first clinical signs of multiple sclerosis (MS), they are...
A British study, published in Frontiers in Neurology journal, has found that cognitive impairment, which is common...
Co-operative stores across the Channel Islands have launched a hidden disabilities scheme for shoppers. People with hidden disabilities such as dementia,...
Exposure to organic solvents, such as varnish and paint can increase the risk of developing multiple sclerosis (MS), according to a large Swedish study. The risk was particularly found in people...
The Government has revealed that it will make a decision on whether it will legalise cannabis for medical use in the coming weeks.
Home Secretary Sajid Javid ordered an evidence review of...
A large population-based cohort study, which looked into the effects of three common air pollutants in people with multiple sclerosis (MS) has found no significant link between long term exposure...
The Department of Health and Social Care has asked the National Institute for Health and Care Excellence (NICE) to produce guidance on using ocrelizumab (Ocrevus) for treating primary progressive...
Cannabinoid Biotech Company Axim has received a patent allowance on its method of extracting and purifying THC (cannabinoid molecule delta-9-tetrahydrocannabinol) in America.
The process...
The National Institute for Health Care and Excellence (NICE) has approved ocrelizumab (Ocrevus) as a treatment option for people with active relapsing remitting multiple sclerosis (RRMS).
...
New guidance, set to come into effect this summer, will mean that people who are awarded the highest level of support under...